Primary Care, Diabetes and Chronic Care
Primary Care, Diabetes and Chronic Care
Dr. Peter Sheehan, a Rumson, NJ native who became an internationally-respected and pioneering force in the field of diabetes, passed away in May during a medical trip to Jamaica. He was 60 years old.
We celebrate the life and mourn the loss of Dr. Sheehan, who was an internationally respected specialist in the field of diabetes. Areas of clinical and research interest for Dr. Sheehan included peripheral artery disease, diabetic neuropathy, and wound healing.
The family here at DiamC mourns the loss of one of our key founders while we continue to celebrate the life and work of Dr. Sheehan through the legacy he has left and the lives he has changed.
Dr. Sheehan was the son of Dr. George Sheehan, the author and advocate of running and exercise, who died in 1993 but remained a strong influence on his son – especially in promoting preventative medicine. Among the younger Dr. Sheehan’s achievements was the development of a multi-disciplined approach to the treatment of diabetes – a method adopted by several healthcare systems.
In addition to his professional achievements, Dr. Sheehan was known by friends and family as much for his razor-like wit and jokes as his medical prowess. “He could light up a room and keep everyone enthralled,” said Andrew Sheehan, one of his 11 siblings. “He loved people of every stripe, and he worked make their lives better.”
A 1972 graduate of Christian Brothers Academy in Lincroft and SUNY-Downstate School of Medicine, Dr. Sheehan completed a fellowship in Endocrinology at the Yale University School of Medicine in New Haven before going into private practice, where he focused on the treatment and care of patients of diabetes.
After serving as director of the Diabetes Treatment Center at Staten Island University Hospital, he created and became medical director of the Diabetes Foot and Ankle Center at NYU Hospital for Joint Diseases, a clinic providing comprehensive care for diabetes sufferers and treatment of foot ulcers before amputation becomes a necessity. In addition to wound care, the clinic works with patients to tame obesity through diet and exercise. Dr. Sheehan believed weight loss to be as important as blood sugar control in treating diabetes.
After leaving the Center, Dr. Sheehan became a senior faculty member at Mt. Sinai School of Medicine, was appointed to the Board of Directors of the American Diabetes Association and served as president of the ADA’s New York City Board.
Under his leadership, the ADA partnered with Mayor Michael Bloomberg to launch the city’s first anti-obesity campaign. He used his positions to become a strong voice for the early detection and treatment of diabetes, which he recognized as a growing health crisis in America disproportionately affecting minorities. “Diabetes is the Hurricane Katrina of American healthcare,” he said.
More recently, Dr. Sheehan founded Sheehan Health Management, a consulting firm developing health management systems such as a world-class diabetes clinical program at Sanford Health USD Medical Center in Sioux Falls, South Dakota. He was in health care management discussions with the government of Jamaica at the time of his death.
Dr. Sheehan is survived by his wife Nadege and their son, Patrick, both of New York City. Also surviving are three children from prior marriage, Caitlin, Peter and Nora, all of New York City. He is survived by all of his 11 brothers and sisters. Funeral arrangements are being arranged by the Frank E. Campbell Funeral Chapel, 1076 Madison Avenue, NY. NY. Phone: 212 288 3500.
Sam Camp began his successful career in pharmaceuticals as a Medical Sales Representative with Rucker Pharmceuticals after graduation from Tulane University. Sam then founded UAD Laboratories which later became Forest Laboratories.
In 1987, he bought Pamlab, moved the corporate office to Covington and began to grow it into the largest pharmaceutical company based in Covington, Louisiana. Pamlab today has coverage in every state of the United States and Puerto Rico as well as a manufacturing plant, Red River Pharma, based in Shreveport.
Since selling Pamlab to Nestlé Health Science in 2012, Sam has continued to be innovative in the areas of biotechnology, the medical foods industry. Through his work with doctors over the years, Sam has developed a keen interest in supporting physicians in their medical practice. Sam formed an organization called Physicians Proviso, to help health care providers achieve autonomy, advocacy and profitability. Additionally, Sam is pioneering a series of new Diabetes Assessment and Management Centers (DiamC).
Sam has been recognized as “Entrepreneur of the Year” and received “The Governor’s Technology Award” for the State of Louisiana. He is on the Board of Trustees of St. Tammany Hospital Foundation, the Board of Trustees for Louisiana College and a member of Northshore-Mandeville Rotary. He attends First Baptist Church, Covington, where he serves on various committees, is an Adult Bible Fellowship leader and a deacon.
Sam has three grown children and six granddaughters. He and Judy have lived in Covington, Louisiana for over four decades.